As will be discussed below, the majority of studies have introduced FOXO3 as a tumor suppressor in gliomas, however; similar to FOXO1, there is a controversial role for FOXO3 in gliomas in terms of function and prognosis [178, 179]. The gene discussed is FOXO1; the disease is central nervous system cancer.